Mims’ Medical Microbiology and Immunology

Höfundur Richard Goering; Hazel M. Dockrell; Mark Zuckerman; Peter L. Chiodini

Útgefandi Elsevier Limited (UK)

Snið ePub

Print ISBN 9780323937252

Útgáfa 7

Útgáfuár 2025

8.890 kr.

Description

Efnisyfirlit

  • Instructions for online access
  • Cover image
  • Title page
  • Copyright
  • Foreword 7th Edition
  • Foreword 6th Edition
  • Preface
  • Contributors
  • Introduction
  • Contents
  • Section 1 The Adversaries – Pathogens
  • 1 Pathogens as parasites
  • Introduction
  • THE VARIETIES OF PATHOGENS
  • LIVING INSIDE OR OUTSIDE CELLS
  • SYSTEMS OF CLASSIFICATION
  • 2 The bacteria
  • Introduction
  • Structure
  • Nutrition
  • Growth and Division
  • Gene Expression
  • Survival Under Adverse Conditions
  • Mobile Genetic Elements
  • Mutation and Gene Transfer
  • The Genomics of Medically Important Bacteria
  • 3 The viruses
  • Introduction
  • MAJOR GROUPS OF VIRUSES
  • INFECTION OF HOST CELLS
  • REPLICATION
  • OUTCOME OF VIRAL INFECTION
  • 4 The fungi
  • Introduction
  • MAJOR GROUPS OF DISEASE-CAUSING FUNGI
  • 5 The protozoa
  • Introduction
  • Protozoa can infect all the major tissues and organs of the body
  • Protozoa have evolved many sophisticated strategies to avoid host responses
  • Protozoa use a variety of routes to infect humans
  • 6 The helminths
  • Introduction
  • LIFE CYCLES
  • HELMINTHS AND DISEASE
  • 7 The arthropods
  • Introduction
  • 8 Prions
  • Introduction
  • A SPECTRUM OF NEURODEGENERATIVE DISORDERS—TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY
  • ROGUE PROTEIN PATHOGENESIS
  • DEVELOPMENT, TRANSMISSION AND DIAGNOSIS OF PRION DISEASES
  • PREVENTION AND TREATMENT OF PRION DISEASES
  • 9 The host–parasite relationship
  • Introduction
  • THE MICROBIOTA AND MICROBIOME
  • SYMBIOTIC ASSOCIATIONS
  • THE CHARACTERISTICS OF PARASITISM
  • THE EVOLUTION OF PARASITISM
  • Section 2 The adversaries – host defences
  • 10 The innate defences of the body
  • Introduction
  • DEFENCES AGAINST ENTRY INTO THE BODY
  • DEFENCES ONCE THE MICROORGANISM PENETRATES THE BODY
  • 11 Adaptive immune responses bring specificity
  • Introduction
  • LYMPHOID TISSUES: PRIMARY AND SECONDARY
  • SECONDARY LYMPHOID ORGANS
  • SUBSETS OF T CELLS
  • ANTIBODY STRUCTURE AND FUNCTION
  • RECIRCULATION OF T AND B CELLS
  • 12 Cooperation leads to effective immune responses
  • Introduction
  • COOPERATION MEANS GREATER EFFICIENCY AND SPECIFICITY
  • OPSONIZATION BY ANTIBODY ENHANCES PHAGOCYTOSIS AND LEADS TO COMPLEMENT ACTIVATION
  • BENEFICIAL INFLAMMATORY REACTIONS CAN ALSO BE ENHANCED BY ANTIBODIES
  • ACTIVATION OF T CELLS INVOLVES ANTIGEN-PRESENTING CELLS AND ADDITIONAL COSTIMULATORY SIGNALS
  • B-CELL ACTIVATION
  • CLONAL EXPANSION
  • ANTIBODY PRODUCTION INVOLVES A SERIES OF STEPS WITHIN THE GERMINAL CENTRE
  • CYTOKINES PLAY AN IMPORTANT PART IN THESE CELL–CELL INTERACTIONS
  • IMMUNOLOGIC MEMORY ENABLES A SECOND INFECTION WITH THE SAME MICROBE TO BE DEALT WITH MORE EFFECTIVELY
  • ARMIES MUST BE KEPT UNDER CONTROL
  • Section 3 The Conflicts
  • 13 Background to the infectious diseases
  • Introduction
  • HOST–PARASITE RELATIONSHIPS
  • CAUSES OF INFECTIOUS DISEASES
  • THE BIOLOGIC RESPONSE GRADIENT
  • 14 Entry, exit and transmission
  • Introduction
  • SITES OF ENTRY
  • EXIT AND TRANSMISSION
  • TYPES OF TRANSMISSION BETWEEN HUMANS
  • TRANSMISSION FROM ANIMALS
  • 15 Immune defences in action
  • Introduction
  • COMPLEMENT
  • ACUTE PHASE PROTEINS AND PATTERN RECOGNITION RECEPTORS
  • FEVER
  • NATURAL KILLER CELLS
  • PHAGOCYTOSIS
  • CYTOKINES
  • ANTIBODY-MEDIATED IMMUNITY
  • CELL-MEDIATED IMMUNITY
  • RECOVERY FROM INFECTION
  • 16 Spread and replication
  • Introduction
  • FEATURES OF SURFACE AND SYSTEMIC INFECTIONS
  • MECHANISMS OF SPREAD THROUGH THE BODY
  • GENETIC DETERMINANTS OF SPREAD AND REPLICATION
  • OTHER FACTORS AFFECTING SPREAD AND REPLICATION
  • 17 Parasite survival strategies and persistent infections
  • Introduction
  • PARASITE SURVIVAL STRATEGIES
  • CONCEALMENT OF ANTIGENS
  • ANTIGENIC VARIATION
  • IMMUNOSUPPRESSION
  • PERSISTENT INFECTIONS
  • 18 Pathologic consequences of infection
  • Introduction
  • PATHOLOGY CAUSED DIRECTLY BY MICROORGANISMS
  • DIARRHOEA
  • PATHOLOGIC ACTIVATION OF NATURAL IMMUNE MECHANISMS
  • PATHOLOGIC CONSEQUENCES OF THE IMMUNE RESPONSE
  • SKIN RASHES
  • VIRUSES AND CANCER
  • Section 4 Clinical Manifestation and Diagnosis of Infections by Body System
  • 19 Upper respiratory tract infections
  • Introduction
  • RHINITIS
  • PHARYNGITIS AND TONSILLITIS
  • PAROTITIS
  • OTITIS AND SINUSITIS
  • ACUTE EPIGLOTTITIS
  • ORAL CAVITY INFECTIONS
  • 20 Lower respiratory tract infections
  • Introduction
  • LARYNGITIS AND TRACHEITIS
  • DIPHTHERIA
  • WHOOPING COUGH
  • ACUTE BRONCHITIS
  • ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS
  • BRONCHIOLITIS
  • RESPIRATORY SYNCYTIAL VIRUS INFECTION
  • HANTAVIRUS PULMONARY SYNDROME
  • PNEUMONIA
  • BACTERIAL PNEUMONIA
  • VIRAL PNEUMONIA
  • HUMAN CORONAVIRUS INFECTIONS
  • PARAINFLUENZA VIRUS INFECTION
  • ADENOVIRUS INFECTION
  • HUMAN METAPNEUMOVIRUS INFECTION
  • HUMAN BOCAVIRUS INFECTION
  • INFLUENZA VIRUS INFECTION
  • MEASLES VIRUS INFECTION
  • CYTOMEGALOVIRUS INFECTION
  • TUBERCULOSIS
  • CYSTIC FIBROSIS
  • LUNG ABSCESS
  • FUNGAL INFECTIONS
  • PARASITIC INFECTIONS
  • 21 Urinary tract infections
  • Introduction
  • ACQUISITION AND AETIOLOGY
  • PATHOGENESIS
  • CLINICAL FEATURES AND COMPLICATIONS
  • LABORATORY DIAGNOSIS
  • TREATMENT
  • PREVENTION
  • 22 Sexually transmitted infections
  • Introduction
  • STIs AND SEXUAL BEHAVIOUR
  • SYPHILIS
  • Gonorrhoea
  • Chlamydial Infection
  • OTHER CAUSES OF INGUINAL LYMPHADENOPATHY
  • Mycoplasmas and Nongonococcal Urethritis
  • OTHER CAUSES OF VAGINITIS AND URETHRITIS
  • Genital Herpes
  • HUMAN PAPILLOMAVIRUS INFECTION
  • Monkeypox, previously a rare viral zoonosis, emerged in 2022 as aN STI
  • HUMAN IMMUNODEFICIENCY VIRUS
  • Opportunist STIs
  • Arthropod Infestations
  • 23 Gastrointestinal tract infections
  • Introduction
  • DIARRHOEAL DISEASES CAUSED BY BACTERIAL OR VIRAL INFECTION
  • FOOD POISONING—BACTERIALTOXIN–ASSOCIATED DIARRHOEA
  • VIRAL CAUSES OF DIARRHOEA
  • HELICOBACTER PYLORI AND GASTRIC ULCER DISEASE
  • PARASITES AND THE GASTROINTESTINAL TRACT
  • MICROSPORIDIA
  • OTHER INTESTINAL PROTOZOA
  • SYSTEMIC INFECTION INITIATED IN THE GASTROINTESTINAL TRACT
  • 24 Obstetric and perinatal infections
  • Introduction
  • INFECTIONS OCCURRING IN PREGNANCY
  • CONGENITAL INFECTIONS
  • INFECTIONS OCCURRING AROUND THE TIME OF BIRTH
  • 25 Central nervous system infections
  • Introduction
  • INVASION OF THE CENTRAL NERVOUS SYSTEM
  • THE BODY’S RESPONSE TO INVASION
  • MENINGITIS
  • ENCEPHALITIS
  • NEUROLOGIC DISEASES OF POSSIBLE VIRAL AETIOLOGY
  • SPONGIFORM ENCEPHALOPATHIES CAUSED BY SCRAPIE-TYPE AGENTS
  • CNS DISEASE CAUSED BY PARASITES
  • BRAIN ABSCESSES
  • TETANUS AND BOTULISM
  • 26 Infections of the eye
  • Introduction
  • CONJUNCTIVITIS
  • INFECTION OF THE DEEPER LAYERS OF THE EYE
  • 27 Infections of the skin, soft tissue, muscle and associated systems
  • Introduction
  • BACTERIAL INFECTIONS OF SKIN, SOFT TISSUE AND MUSCLE
  • MYCOBACTERIAL DISEASES OF THE SKIN
  • FUNGAL INFECTIONS OF THE SKIN
  • PARASITIC INFECTIONS OF THE SKIN
  • MUCOCUTANEOUS MANIFESTATIONS OF VIRAL INFECTIONS
  • MEASLES VIRUS INFECTION
  • RUBELLA VIRUS INFECTION
  • OTHER MACULOPAPULAR RASHES ASSOCIATED WITH VIRAL INFECTIONS
  • OTHER INFECTIONS PRODUCING SKIN LESIONS
  • KAWASAKI DISEASE
  • VIRAL INFECTIONS OF MUSCLE
  • POSTVIRAL FATIGUE SYNDROME
  • PARASITIC INFECTIONS OF MUSCLE
  • JOINT AND BONE INFECTIONS
  • INFECTIONS OF THE HAEMOPOIETIC SYSTEM
  • 28 Vectorborne infections
  • Introduction
  • ARBOVIRUS INFECTIONS
  • INFECTIONS CAUSED BY RICKETTSIAE
  • BORRELIA INFECTIONS
  • PROTOZOAL INFECTIONS
  • HELMINTH INFECTIONS
  • 29 Multisystem zoonoses
  • Introduction
  • Viral haemorrhagic fever is a multisystem syndrome triggered by a group of viruses that cause severe damage to the vascular system
  • ARENAVIRUS INFECTIONS
  • EBOLA AND MARBURG HAEMORRHAGIC FEVERS
  • Q FEVER
  • ANTHRAX
  • PLAGUE
  • YERSINIA ENTEROCOLITICA INFECTION
  • TULARAEMIA
  • PASTEURELLA MULTOCIDA INFECTION
  • LEPTOSPIROSIS
  • RAT-BITE FEVER
  • BRUCELLOSIS
  • HELMINTH INFECTIONS
  • 30 Fever of unknown origin
  • Introduction
  • DEFINITIONS OF FEVER OF UNKNOWN ORIGIN
  • CAUSES OF FUO
  • INVESTIGATION OF CLASSIC FUO
  • TREATMENT OF FUO
  • FUO IN SPECIFIC PATIENT GROUPS
  • INFECTIVE ENDOCARDITIS
  • 31 Infections in the compromised host
  • Introduction
  • THE COMPROMISED HOST
  • INFECTIONS OF THE HOST WITH DEFICIENT INNATE IMMUNITY DUE TO PHYSICAL FACTORS
  • INFECTIONS ASSOCIATED WITH SECONDARY ADAPTIVE IMMUNODEFICIENCY
  • OTHER IMPORTANT OPPORTUNIST PATHOGENS
  • Section 5 Diagnosis and Control
  • 32 Diagnosis of infection and assessment of host defence mechanisms
  • Introduction
  • AIMS OF THE CLINICAL MICROBIOLOGY LABORATORY
  • SPECIMEN PROCESSING
  • CULTIVATION (CULTURE) OF MICROORGANISMS
  • IDENTIFICATION OF MICROORGANISMS GROWN IN CULTURE
  • NONCULTURAL TECHNIQUES FOR THE LABORATORY DIAGNOSIS OF INFECTION
  • ANTIBODY DETECTION METHODS FOR THE DIAGNOSIS OF INFECTION
  • ASSESSMENT OF HOST DEFENCE SYSTEMS
  • PUTTING IT ALL TOGETHER: DETECTION, DIAGNOSIS, EPIDEMIOLOGY
  • 33 Epidemiology and control of infectious diseases
  • Introduction
  • WHAT IS EPIDEMIOLOGY?
  • OUTCOME MEASUREMENTS
  • TYPES OF EPIDEMIOLOGIC STUDIES
  • TRANSMISSION OF INFECTIOUS DISEASE
  • VACCINE EFFICACY
  • 34 Attacking the enemy: antimicrobial agents and chemotherapy
  • Introduction
  • SELECTIVE TOXICITY
  • DISCOVERY AND DESIGN OF ANTIMICROBIAL AGENTS
  • CLASSIFICATION OF ANTIBACTERIAL AGENTS
  • RESISTANCE TO ANTIBACTERIAL AGENTS
  • CLASSES OF ANTIBACTERIAL AGENTS
  • INHIBITORS OF CELL WALL SYNTHESIS
  • INHIBITORS OF PROTEIN SYNTHESIS
  • INHIBITORS OF NUCLEIC ACID SYNTHESIS
  • ANTIMETABOLITES AFFECTING NUCLEIC ACID SYNTHESIS
  • OTHER AGENTS THAT AFFECT DNA
  • INHIBITORS OF CYTOPLASMIC MEMBRANE FUNCTION
  • URINARY TRACT ANTISEPTICS
  • ANTITUBERCULOSIS AGENTS
  • ANTIBACTERIAL AGENTS IN PRACTICE
  • ANTIBIOTIC ASSAYS
  • ANTIVIRAL THERAPY
  • ANTIFUNGAL AGENTS
  • ANTIPARASITIC AGENTS
  • CONTROL BY CHEMOTHERAPY VERSUS VACCINATION
  • CONTROL VERSUS ERADICATION
  • USE AND MISUSE OF ANTIMICROBIAL AGENTS
  • 35 Protecting the host: vaccination
  • Introduction
  • VACCINATION—A 400-YEAR HISTORY
  • Edward Jenner (1749–1823)
  • AIMS OF VACCINATION
  • VACCINES CAN BE OF DIFFERENT TYPES
  • Live attenuated vaccines
  • Nonliving vaccines
  • Genetically engineered vaccines
  • NONSPECIFIC BENEFICIAL EFFECTS OF VACCINES
  • Vaccines in current use
  • New vaccines in development
  • 36 Specific and nonspecific immunotherapy
  • Introduction
  • ADOPTIVE IMMUNOTHERAPY WITH T CELLS
  • PASSIVE IMMUNOTHERAPY WITH ANTIBODIES
  • NONSPECIFIC CELLULAR MODULATION
  • CORRECTION OF HOST IMMUNODEFICIENCY
  • 37 Infection control
  • COMMON HOSPITAL INFECTIONS
  • IMPORTANT CAUSES OF HOSPITAL INFECTION
  • Urinary tract infections
  • Surgical wound infections
  • Pneumonia
  • Bloodstream infections
  • Gastrointestinal infections
  • SOURCES AND ROUTES OF SPREAD OF HOSPITAL INFECTION
  • HOST FACTORS AND HOSPITAL INFECTION
  • CONSEQUENCES OF HOSPITAL INFECTION
  • PREVENTION OF HOSPITAL INFECTION
  • INVESTIGATING HAI
  • STERILIZATION AND DISINFECTION
  • Index
  • Pathogen parade
  • Viruses
  • Hepatitis Viruses
  • Bacteria
  • Beta-Haemolytic Streptococci
  • Alpha-Haemolytic Streptococci
  • Gram-Positive Rods
  • Gram-Negative Rods
  • Other Bacteria
  • Fungi
  • Helminths
  • Vaccine parade
  • Section 1: The Adversaries—Pathogens
  • Section 2: The Adversaries—Host Defences
  • Section 3: The Conflicts
  • Section 4: Clinical Manifestation and Diagnosis of Infections by Body System
  • Section 5: Diagnosis and Control
  • Online Cases
  • Bibliography – list of useful websites
Show More

Additional information

Veldu vöru

Rafbók til eignar

Aðrar vörur

0
    0
    Karfan þín
    Karfan þín er tómAftur í búð